[go: up one dir, main page]

CN113736737B - A method for culturing primary glioma-related fibroblasts - Google Patents

A method for culturing primary glioma-related fibroblasts Download PDF

Info

Publication number
CN113736737B
CN113736737B CN202111097340.7A CN202111097340A CN113736737B CN 113736737 B CN113736737 B CN 113736737B CN 202111097340 A CN202111097340 A CN 202111097340A CN 113736737 B CN113736737 B CN 113736737B
Authority
CN
China
Prior art keywords
tissue
cell
culture
primary
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111097340.7A
Other languages
Chinese (zh)
Other versions
CN113736737A (en
Inventor
左明荣
刘艳辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
West China Hospital of Sichuan University
Original Assignee
West China Hospital of Sichuan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West China Hospital of Sichuan University filed Critical West China Hospital of Sichuan University
Priority to CN202111097340.7A priority Critical patent/CN113736737B/en
Publication of CN113736737A publication Critical patent/CN113736737A/en
Application granted granted Critical
Publication of CN113736737B publication Critical patent/CN113736737B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656Adult fibroblasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/11Epidermal growth factor [EGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10Mechanical dissociation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

一种原代胶质瘤相关成纤维细胞培养方法,通过创新性联合使用细胞差异贴壁法、细胞营养筛选法,该新式培养方法能够避免原代细胞培养过程中混杂大量非成纤维细胞所带来的细胞筛选困难。该新方法仅用容易获取的常规试剂便能达到超过传统方法的优良效果,在较短时间内实现P0代细胞完全纯化,值得推广。目前本课题组已经从46个新鲜人胶质瘤组织中培养出37例胶质瘤相关成纤维细胞,成功率高达80%。现有的快速实现肿瘤相关成纤维细胞培养的方法主要通过流式细胞分选或者磁珠分选,仪器、试剂价格昂贵,实验技术复杂,操作难度较高;而该细胞培养法的发明对于实验研究的经济性具有重要价值。

A primary glioma-related fibroblast culture method. Through the innovative combination of differential cell adhesion method and cell nutrient screening method, this new culture method can avoid the contamination of a large number of non-fibroblasts during the primary cell culture process. Cell screening is difficult. This new method can achieve superior results than traditional methods using only easily available conventional reagents, and can achieve complete purification of P0 generation cells in a relatively short period of time, which is worthy of promotion. Currently, our research group has cultured 37 cases of glioma-related fibroblasts from 46 fresh human glioma tissues, with a success rate of 80%. The existing methods for quickly cultivating tumor-related fibroblasts are mainly through flow cell sorting or magnetic bead sorting. The instruments and reagents are expensive, the experimental technology is complex, and the operation is difficult; and the invention of this cell culture method is very difficult for experiments. The economics of research are of great value.

Description

一种原代胶质瘤相关成纤维细胞培养方法A method for culturing primary glioma-related fibroblasts

技术领域Technical field

本发明涉及细胞培养方法领域,特别涉及一种原代胶质瘤相关成纤维细胞培养方法。The present invention relates to the field of cell culture methods, and in particular to a primary glioma-related fibroblast culture method.

背景技术Background technique

原代胶质瘤相关成纤维细胞尚无有效的培养方法。There is no effective culture method for primary glioma-associated fibroblasts.

现有的培养方法之一:无菌流式细胞分选或者磁珠分选,需要昂贵仪器以及流式抗体,对实验条件、操作技术要求很高,经济型、便捷性很差。One of the existing culture methods: sterile flow cell sorting or magnetic bead sorting, requires expensive instruments and flow antibodies, has high requirements on experimental conditions and operating techniques, and is poor in economy and convenience.

若采用传统培养方法,如营养筛选法则需要等待细胞传代数代之后方能获取纯化原代成纤维细胞,大大减少成纤维细胞后续实验可利用代数;此外成纤维细胞增殖速度很慢,培养周期长。If traditional culture methods are used, such as the nutritional screening method, it is necessary to wait for several generations of cell passage before obtaining purified primary fibroblasts, which greatly reduces the number of generations of fibroblasts that can be used for subsequent experiments; in addition, the proliferation rate of fibroblasts is very slow and the culture cycle is long. .

综上述,胶质瘤相关成纤维细胞培养亟须解决培养周期长,细胞纯化困难、价格昂贵等难题。In summary, the culture of glioma-related fibroblasts urgently needs to solve the problems of long culture cycle, difficult cell purification, and high price.

发明内容Contents of the invention

为解决上述现有技术存在的问题,本发明的目的在于提供一种原代胶质瘤相关成纤维细胞培养方法。In order to solve the problems existing in the above-mentioned prior art, the purpose of the present invention is to provide a primary glioma-related fibroblast culture method.

为达到上述目的,本发明的技术方案为:In order to achieve the above objects, the technical solution of the present invention is:

一种原代胶质瘤相关成纤维细胞培养方法,包括如下步骤:A method for culturing primary glioma-related fibroblasts, including the following steps:

步骤a、洗涤组织:将肿瘤组织放置于冰面上的无菌培养皿中,取组织洗涤缓冲液清洗组织血凝块两遍;眼科剪剪碎组织块直至成为糊状;Step a. Wash the tissue: Place the tumor tissue in a sterile petri dish on ice, take tissue washing buffer to wash the tissue blood clot twice; cut the tissue block with ophthalmic scissors until it becomes paste;

步骤b、消化组织:Step b. Digest tissue:

向剪碎的组织中加入组织消化酶解液1,立即采用移液管将组织悬液转移至15ml试管后并轻柔吹打,37℃温浴5分钟,再次吹打悬液后温浴5分钟;Add tissue digestion enzyme solution 1 to the minced tissue, immediately transfer the tissue suspension to a 15ml test tube with a pipette and gently pipet, incubate at 37°C for 5 minutes, pipet the suspension again and incubate for 5 minutes;

向上述组织悬液中继续添加组织消化酶解液2继续于37℃温浴5分钟,再次吹打悬液后温浴5分钟;当组织悬液能够用1mL移液枪顺利吸取,表示消化完成;Continue to add tissue digestion enzymatic solution 2 to the above tissue suspension and continue to incubate at 37°C for 5 minutes. Pipet the suspension again and incubate for 5 minutes. When the tissue suspension can be smoothly absorbed with a 1mL pipette, the digestion is complete;

步骤c、过滤:向组织悬液中加入10mL PBS,吹匀后采用70μm细胞滤网过滤,将所获细胞悬液离心,400xg 3分钟,弃上清;Step c. Filtration: Add 10 mL PBS to the tissue suspension, blow evenly and filter through a 70 μm cell strainer. Centrifuge the obtained cell suspension at 400xg for 3 minutes and discard the supernatant;

步骤d、去除红细胞:向细胞沉渣中加入3倍于细胞沉淀体积的1x红细胞裂解液,室温静置5分钟;向细胞悬液中加入8mL PBS,离心后弃上清;Step d. Remove red blood cells: Add 1x red blood cell lysis buffer 3 times the volume of cell sedimentation to the cell sediment, and let stand at room temperature for 5 minutes; add 8 mL PBS to the cell suspension, centrifuge and discard the supernatant;

步骤e、原代成纤维细胞培养:现配肿瘤干细胞培养液10mL,取10mL原代细胞培养液1,并添加1000x EGF、1000x bFGF各10μL(终浓度20ng/ml),细胞计数,2x106个细胞加入培养液,培养24h。弃掉培养皿上清,PBS清洗并轻拍培养皿底部三遍,镜下观察细胞碎片及沉渣完全清洗干净后想培养皿内添加MSC培养基;三天后观察细胞形态以及生长情况并换液,拍照记录。Step e. Primary fibroblast culture: Prepare 10 mL of cancer stem cell culture medium, take 10 mL of primary cell culture medium 1, and add 10 μL each of 1000x EGF and 1000x bFGF (final concentration 20 ng/ml). Count the cells, 2x10 6 Cells were added to culture medium and cultured for 24 h. Discard the supernatant of the culture dish, wash with PBS and tap the bottom of the culture dish three times. Observe the cell debris and sediment under the microscope. After cleaning, add MSC culture medium to the culture dish. After three days, observe the cell morphology and growth and change the medium. Take photos and record.

步骤f、原代胶质瘤相关成纤维细胞培养及传代:当P0代细胞汇聚度为90%左右,消化酶(0.25%胰酶+EDTA)消化细胞,将细胞悬液离心3min,400xg;更换10%FBS-DMEM全培养液继续培养(1x106个细胞/75cm2)。(注意:原代细胞传代次数应少于10代,避免可能出现遗传和表型变化。)Step f. Culture and passage of primary glioma-related fibroblasts: When the confluence of P0 generation cells is about 90%, digest the cells with digestive enzymes (0.25% trypsin + EDTA), and centrifuge the cell suspension for 3 minutes at 400xg; replace Continue culturing in 10% FBS-DMEM complete culture medium (1x10 6 cells/75cm 2 ). (Note: The number of primary cell passages should be less than 10 generations to avoid possible genetic and phenotypic changes.)

进一步的,所述组织消化酶解液1为:组织解离液1.85mL+木瓜蛋白酶储备液100μL现用现加脱氧核糖核酸酶-I 50μL,-20℃保存;组织解离液:去离子水(441mL)+10x Hank’s平衡盐溶液(50mL)+D-葡萄糖溶液(300mg/mL)(9mL),-20℃保存。Further, the tissue digestion enzymatic solution 1 is: 1.85 mL of tissue dissociation solution + 100 μL of papain stock solution, 50 μL of deoxyribonuclease-I is added and stored at -20°C; tissue dissociation solution: deionized water ( 441mL) + 10x Hank's balanced salt solution (50mL) + D-glucose solution (300mg/mL) (9mL), store at -20°C.

进一步的,所述组织消化酶解液2:组织解离液(100mL)+胶原酶-I(70mg)+透明质酸酶(70mg),充分溶解后分装,-20℃保存。Further, the tissue digestion enzymatic solution 2: tissue dissociation solution (100 mL) + collagenase-I (70 mg) + hyaluronidase (70 mg), fully dissolved, aliquoted, and stored at -20°C.

进一步的,所述原代细胞培养液1:DMEM/F12(480mL)+青-链霉素(5mL)+50x B27(10mL),4℃保存。Further, the primary cell culture medium 1: DMEM/F12 (480 mL) + penicillin-streptomycin (5 mL) + 50x B27 (10 mL), stored at 4°C.

进一步的,所述原代细胞培养液2:间充质干细胞培养液,4℃保存。Further, the primary cell culture medium 2: mesenchymal stem cell culture medium, stored at 4°C.

进一步的,所述1000x b-FGF:b-FGF(50μg)+去离子水(2.5mL)+牛血清蛋白(2.5mg),无菌滤网过滤,-20℃保存。Further, the 1000x b-FGF: b-FGF (50 μg) + deionized water (2.5 mL) + bovine serum albumin (2.5 mg), filtered through a sterile filter, and stored at -20°C.

进一步的,所述10%FBS-DMEM:FBS(50mL)+DMEM(445mL)+P/S(5mL),4℃保存。Further, the 10% FBS-DMEM: FBS (50 mL) + DMEM (445 mL) + P/S (5 mL), stored at 4°C.

相对于现有技术,本发明的有益效果为:Compared with the existing technology, the beneficial effects of the present invention are:

1、原理创新:通过创新性联合使用细胞差异贴壁法、细胞营养筛选法,该新式培养方法能够避免原代细胞培养过程中混杂大量非成纤维细胞所带来的细胞筛选困难。1. Principle innovation: Through the innovative combination of differential cell adhesion method and cell nutrient screening method, this new culture method can avoid the difficulty of cell selection caused by mixing a large number of non-fibroblasts in the primary cell culture process.

2、便捷:该新方法仅用容易获取的常规试剂便能达到超过传统方法的优良效果,在较短时间内实现P0代细胞完全纯化,值得推广。2. Convenience: This new method can achieve superior results than traditional methods by using only easily available conventional reagents, and can achieve complete purification of P0 generation cells in a relatively short period of time, which is worthy of promotion.

3、高效:目前本课题组已经从46个新鲜人胶质瘤组织中培养出37例胶质瘤相关成纤维细胞,成功率高达80%。3. High efficiency: Currently, our research group has cultured 37 cases of glioma-related fibroblasts from 46 fresh human glioma tissues, with a success rate of 80%.

4、经济:现有的快速实现肿瘤相关成纤维细胞培养的方法主要通过流式细胞分选或者磁珠分选,仪器、试剂价格昂贵,实验技术复杂,操作难度较高;而该细胞培养法的发明对于实验研究的经济性具有重要价值。4. Economical: The existing methods for quickly cultivating tumor-related fibroblasts mainly use flow cell sorting or magnetic bead sorting. The instruments and reagents are expensive, the experimental technology is complex, and the operation is difficult; and this cell culture method The invention is of great value to the economy of experimental research.

附图说明Description of the drawings

图1为原代胶质瘤相关成纤维细胞培养流程图。Figure 1 is a flow chart of primary glioma-related fibroblast culture.

图2为原代胶质瘤相关成纤维细胞光镜形态图。Figure 2 shows the light microscope morphology of primary glioma-related fibroblasts.

图3为成纤维细胞免疫荧光染色图:FAP(绿色),Fibronectin(红色)。Figure 3 shows the immunofluorescence staining of fibroblasts: FAP (green), Fibronectin (red).

图4成纤维细胞特征性标记物αSMA在胶质瘤相关成纤维细胞中高表达。Figure 4 αSMA, a characteristic marker of fibroblasts, is highly expressed in glioma-related fibroblasts.

具体实施方式Detailed ways

下面结合附图(图1-4)和具体实施方式对本发明技术方案做进一步详细描述:The technical solution of the present invention will be further described in detail below in conjunction with the accompanying drawings (Figures 1-4) and specific implementation modes:

一、器械与试剂1. Instruments and reagents

冰盒、碎冰块、眼科剪、眼科镊、6cm细胞培养皿、10cm细胞培养皿、封口膜、15mL离心管、50mL离心管、0.22μM无菌滤网、恒温水浴锅、高速离心机、移液管、Eppendorf移液枪、Thermo细胞移液器Ice box, crushed ice, ophthalmic scissors, ophthalmic tweezers, 6cm cell culture dish, 10cm cell culture dish, sealing film, 15mL centrifuge tube, 50mL centrifuge tube, 0.22μM sterile filter, constant temperature water bath, high-speed centrifuge, transfer Liquid tubes, Eppendorf pipettes, Thermo cell pipettes

1、试剂1. Reagents

磷酸盐缓冲盐溶液(PBS)、青-链霉素、木瓜蛋白酶、透明质酸酶、胶原酶-I、胰酶、MSC培养液、DMEM/F12培养液、碱性成纤维细胞生长因子(bFGF)、表皮细胞生长因子(EGF)、B-12、胎牛血清(FBS)、高糖培养基(DMEM)、10x红细胞裂解液、去离子水(UP-H2O)、牛血清白蛋白(BSA)、D-葡萄糖、EBSS、脱氧核糖核酸酶-IPhosphate buffered saline (PBS), penicillin-streptomycin, papain, hyaluronidase, collagenase-I, trypsin, MSC culture medium, DMEM/F12 culture medium, basic fibroblast growth factor (bFGF ), epidermal growth factor (EGF), B-12, fetal bovine serum (FBS), high glucose medium (DMEM), 10x red blood cell lysate, deionized water (UP-H 2 O), bovine serum albumin ( BSA), D-glucose, EBSS, deoxyribonuclease-I

2、工作液配置2. Working fluid configuration

a、新鲜肿瘤组织保存液:1%青霉素-链霉素(5mL)+99%磷酸盐缓冲盐溶液(495mL)。a. Fresh tumor tissue preservation solution: 1% penicillin-streptomycin (5mL) + 99% phosphate buffered saline solution (495mL).

b、组织洗涤缓冲液:磷酸盐缓冲盐溶液(450mL)+牛血清白蛋白(5g)+青霉素-链霉素(5mL),0.22μM无菌滤网过滤,4℃保存。b. Tissue washing buffer: phosphate buffered saline solution (450mL) + bovine serum albumin (5g) + penicillin-streptomycin (5mL), filtered through a 0.22μM sterile filter, and stored at 4°C.

c、组织解离液:去离子水(441mL)+10x Hank’s平衡盐溶液(50mL)+D-glucose溶液(300mg/mL)(9mL),-20℃保存。c. Tissue dissociation solution: deionized water (441mL) + 10x Hank’s balanced salt solution (50mL) + D-glucose solution (300mg/mL) (9mL), stored at -20°C.

d、木瓜蛋白酶储备液:木瓜蛋白酶(20mg)+EBSS(1mL),0.22μM无菌滤网过滤,4℃保存。d. Papain stock solution: papain (20 mg) + EBSS (1 mL), filtered through a 0.22 μM sterile filter, and stored at 4°C.

e、组织消化酶解液1:组织解离液(1.85mL)+木瓜蛋白酶储备液(100μL现用现加)+脱氧核糖核酸酶-I(50μL),-20℃保存。e. Tissue digestion enzymatic solution 1: tissue dissociation solution (1.85 mL) + papain stock solution (100 μL ready for use) + deoxyribonuclease-I (50 μL), stored at -20°C.

f、组织消化酶解液2:组织解离液(100mL)+胶原酶-I(70mg)+透明质酸酶(70mg),充分溶解后分装,-20℃保存。f. Tissue digestion enzymatic solution 2: Tissue dissociation solution (100mL) + Collagenase-I (70mg) + Hyaluronidase (70mg). After fully dissolving, aliquot and store at -20°C.

g、1x红细胞裂解液:10x红细胞裂解液(10mL)+无菌蒸馏水(90mL)。g. 1x red blood cell lysis solution: 10x red blood cell lysis solution (10mL) + sterile distilled water (90mL).

h、原代细胞培养液1:96%DMEM/F12培养基(480mL)+1%P/S(5mL)+2%B27(50x)(10mL),4℃保存。h. Primary cell culture medium 1: 96% DMEM/F12 medium (480 mL) + 1% P/S (5 mL) + 2% B27 (50x) (10 mL), stored at 4°C.

i、原代细胞培养液2:间充质干细胞培养液,4℃保存。i. Primary cell culture medium 2: mesenchymal stem cell culture medium, stored at 4°C.

j、1000x碱性成纤维细胞生长因子:b-FGF(50μg)+去离子水(2.5mL)+牛血清白蛋白(2.5mg),无菌滤网过滤,-20℃保存。j. 1000x basic fibroblast growth factor: b-FGF (50 μg) + deionized water (2.5 mL) + bovine serum albumin (2.5 mg), filtered through a sterile filter, and stored at -20°C.

k、1000x表皮细胞生长因子(EGF):,无菌滤网过滤,-20℃保存。k. 1000x epidermal growth factor (EGF): filtered through a sterile filter and stored at -20°C.

l、10%胎牛血清(FBS)-高糖培养基(DMEM):10%胎牛血清(50mL)+89%高糖培养基(445mL)+1%青霉素-链霉素(5mL),4℃保存。l. 10% fetal bovine serum (FBS)-high glucose medium (DMEM): 10% fetal bovine serum (50mL) + 89% high glucose medium (445mL) + 1% penicillin-streptomycin (5mL), 4 Store at ℃.

二、操作步骤2. Operation steps

a、洗涤组织:将肿瘤组织放置于冰面上的无菌6cm培养皿中,取组织洗涤缓冲液清洗组织血凝块两遍;眼科剪剪碎组织块直至成为糊状。a. Wash the tissue: Place the tumor tissue in a sterile 6cm petri dish on ice, take tissue washing buffer to wash the tissue blood clot twice; cut the tissue block with ophthalmic scissors until it becomes paste.

b、消化组织:b. Digestive tissue:

向剪碎的组织中加入组织消化酶解液1,采用移液管将组织悬液转移至15ml试管后并轻柔吹打,37℃温浴5分钟,再次吹打悬液后温浴5分钟;Add tissue digestion enzyme hydrolyzate 1 to the minced tissue, transfer the tissue suspension to a 15ml test tube with a pipette and pipe gently, incubate at 37°C for 5 minutes, pipet the suspension again and incubate for 5 minutes;

向上述组织悬液中继续添加组织消化酶解液2重悬组织,37℃温浴5分钟,再次吹打悬液后温浴5分钟;当组织悬液能够用1mL移液枪顺利吸取,表示消化完成。Continue to add tissue digestion enzymatic solution 2 to the above tissue suspension to resuspend the tissue, incubate at 37°C for 5 minutes, pipet the suspension again and incubate for 5 minutes; when the tissue suspension can be smoothly absorbed with a 1mL pipette, the digestion is complete.

c、过滤:向组织悬液中加入10mL PBS,吹匀后采用70μM细胞滤网过滤,将所获细胞悬液离心,400xg 3分钟,弃上清。c. Filtration: Add 10 mL of PBS to the tissue suspension, blow evenly and filter with a 70 μM cell strainer. Centrifuge the obtained cell suspension at 400xg for 3 minutes and discard the supernatant.

d、去除红细胞:向细胞沉渣中加入1x红细胞裂解液(3倍于细胞沉淀体积),室温静置5分钟;向细胞悬液中加入8mL PBS,离心后弃上清。d. Remove red blood cells: Add 1x red blood cell lysis buffer (3 times the cell sedimentation volume) to the cell sediment and let it stand at room temperature for 5 minutes; add 8mL PBS to the cell suspension, centrifuge and discard the supernatant.

e、原代成纤维细胞培养(关键):现配肿瘤干细胞培养液10mL,取10mL原代细胞培养液1,并添加1000x EGF、1000x bFGF各10μL(终浓度20ng/ml),细胞计数,2x106个细胞加入培养液,培养24h。弃掉培养皿上清,PBS清洗并轻拍培养皿底部三遍,镜下观察细胞碎片及沉渣完全清洗干净后想培养皿内添加MSC培养基;三天后观察细胞形态以及生长情况并换液,拍照记录。e. Primary fibroblast culture (key): Now prepare 10 mL of cancer stem cell culture medium, take 10 mL of primary cell culture medium 1, and add 10 μL each of 1000x EGF and 1000x bFGF (final concentration 20 ng/ml), and count the cells, 2x10 6 cells were added to the culture medium and cultured for 24 hours. Discard the supernatant of the culture dish, wash with PBS and tap the bottom of the culture dish three times. Observe the cell debris and sediment under the microscope. After cleaning, add MSC culture medium to the culture dish. After three days, observe the cell morphology and growth and change the medium. Take photos and record.

f、原代胶质瘤相关成纤维细胞培养及传代:当P0代细胞汇聚度为90%左右,消化酶(0.25%胰酶+EDTA)消化细胞,将细胞悬液离心3min,400xg;更换10%FBS-DMEM全培养液继续培养(1x106个细胞/75cm2)。(注意:原代细胞传代次数应少于10代,避免可能出现遗传和表型变化。)f. Culture and passage of primary glioma-related fibroblasts: When the confluence of P0 generation cells is about 90%, digest the cells with digestive enzymes (0.25% trypsin + EDTA), and centrifuge the cell suspension for 3 minutes at 400xg; replace 10 Continue culturing in %FBS-DMEM complete culture medium (1x10 6 cells/75cm 2 ). (Note: The number of primary cell passages should be less than 10 generations to avoid possible genetic and phenotypic changes.)

以上细胞培养操作流程见图1:获取新鲜人脑胶质瘤组织,分别经过物理剪切、化学消化获取单细胞悬液;进而采用全新的原代胶质瘤相关成纤维细胞培养方式:先用肿瘤干细胞培养液悬浮培养原代细胞(筛选贴壁能力强的成纤维细胞),24小时后去除上清中未贴壁细胞后更换MSC培养液继续培养。The above cell culture operation process is shown in Figure 1: fresh human brain glioma tissue is obtained, and single cell suspension is obtained through physical shearing and chemical digestion respectively; then a new primary glioma-related fibroblast culture method is used: first The primary cells were cultured in suspension in the cancer stem cell culture medium (to select fibroblasts with strong adhesion ability). After 24 hours, the non-adherent cells in the supernatant were removed and the MSC culture medium was replaced to continue culturing.

如图2所示,对于成功培养的原代细胞,其细胞形态与肿瘤相关成纤维细胞相似,但与胶质瘤细胞形态差异很大;此外细胞培养效率很高,在第0代第15天左右原代成纤维细胞汇聚度能达到90%,且细胞形态均一,几乎无其它非成纤维细胞存在。As shown in Figure 2, for successfully cultured primary cells, their cell morphology is similar to tumor-associated fibroblasts, but very different from glioma cell morphology; in addition, the cell culture efficiency is very high, on day 15 of passage 0 The confluence of left and right primary fibroblasts can reach 90%, and the cell morphology is uniform, with almost no other non-fibroblasts present.

利用细胞免疫荧光检测了原代细胞是否高表达已知的肿瘤相关成纤维细胞细胞分子标记物,例如成纤维细胞激活蛋白(FAP)、纤连蛋白(Fibronectin),结果提示上述形态符合成纤维细胞特征的原代细胞均高表达成纤维细胞特异性标记物,如图3所示。说明该方法能够有效、快速培养出胶质瘤相关成纤维细胞。Cellular immunofluorescence was used to detect whether the primary cells highly expressed known tumor-associated fibroblast cell molecular markers, such as fibroblast activating protein (FAP) and fibronectin (Fibronectin). The results suggested that the above morphology was consistent with fibroblasts. The characterized primary cells all highly expressed fibroblast-specific markers, as shown in Figure 3. This shows that this method can effectively and quickly culture glioma-related fibroblasts.

最后,通过West Blot分别检测原代成纤维细胞、胶质瘤细胞系(U251)、间充质干细胞(MSC)成纤维细胞特异性标记物αSMA的表达水平,结果提示胶质瘤相关成纤维细胞高表达αSMA,这与阳性对照间充质干细胞表达情况相同,而阴性对照细胞U251则不表达αSMA,再次提示该方法培养出的原代细胞属于成纤维细胞。Finally, West Blot was used to detect the expression levels of the fibroblast-specific marker αSMA in primary fibroblasts, glioma cell lines (U251), and mesenchymal stem cells (MSC). The results suggested that glioma-associated fibroblasts αSMA is highly expressed, which is the same as the expression of positive control mesenchymal stem cells, while the negative control cell U251 does not express αSMA, again suggesting that the primary cells cultured by this method belong to fibroblasts.

以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何不经过创造性劳动想到的变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应该以权利要求书所限定的保护范围为准。The above are only specific embodiments of the present invention, but the protection scope of the present invention is not limited thereto. Any changes or substitutions that are not thought of through creative efforts should be covered by the protection scope of the present invention. Therefore, the protection scope of the present invention should be subject to the protection scope defined by the claims.

Claims (4)

1. A primary glioma-associated fibroblast cell culture method, comprising the steps of:
step a, washing tissues: placing tumor tissue in a sterile culture dish on ice surface, and taking tissue washing buffer solution to wash tissue blood clot twice; ophthalmic scissors break up tissue blocks until they become pasty;
step b, digesting the tissue:
adding the tissue digestion enzyme solution 1 into the sheared tissues, immediately transferring the tissue suspension to a 15ml test tube by using a pipette, gently blowing, carrying out warm bath at 37 ℃ for 5 minutes, and carrying out warm bath after blowing the suspension again for 5 minutes;
continuously adding tissue digestion enzymolysis liquid 2 into the tissue suspension to resuspend the tissue, carrying out warm bath for 5 minutes at 37 ℃, and carrying out warm bath for 5 minutes after blowing the suspension again; when the tissue suspension can be successfully sucked by a 1mL pipette, the digestion is completed;
step c, filtering: adding 10mL of PBS into the tissue suspension, uniformly blowing, filtering by adopting a 70 mu M cell filter screen, centrifuging the obtained cell suspension for 400Xg 3 minutes, and discarding the supernatant;
step d, removing red blood cells: adding 1x erythrocyte lysate 3 times the volume of the cell sediment into the cell sediment, and standing for 5 minutes at room temperature; adding 8mL of PBS to the cell suspension, centrifuging, and discarding the supernatant;
step e, primary fibroblast culture: preparing 10mL of tumor stem cell culture solution, taking 10mL of primary cell culture solution 1, and adding 10 mu L of 1000 XEGF and 1000 Xb-FGF respectively; final concentration 20ng/ml, cell count, 2X10 6 The individual cells were added to the culture medium and cultured for 24 hours. Discarding the culture dish supernatant, washing with PBS and tapping the bottom of the culture dish for three times, observing cell fragments and sediments under a mirror, and adding MSC culture medium into the culture dish after completely washing; observing cell morphology and growth condition after three days, changing liquid, photographing and recording;
step f, primary glioma-related fibroblast culture and passage: when the pooling degree of the P0 generation cells is 90%, digesting the cells with 0.25% pancreatin and EDTA, centrifuging the cell suspension for 3min and 400g; the whole culture solution of 10% FBS-DMEM is replaced for continuous culture, and the culture is 1 multiplied by 10 6 Individual cells/75 cm 2
The tissue digestion enzymolysis liquid 1 is as follows: 1.85mL of tissue dissociation solution, 100 [ mu ] L of papain stock solution, 50 [ mu ] L of currently-used adding DNA (deoxyribonucleic acid) enzyme, and-20 ℃ below zero; tissue dissociation liquid: 300mg/mL of deionized water +10XHBSS +D-glucose solution and preserving at-20 ℃;
the tissue digestion enzymolysis liquid 2: tissue dissociation solution, collagenase-I and hyaluronidase, and packaging after full dissolution, and preserving at-20deg.C;
the primary cell culture fluid 1: DMEM/f12+green-streptomycin+50×b27, stored at 4 ℃;
2. the method of claim 1, wherein the 1000 xb-FGF: b-FGF+deionized water+BSA, sterile filtration sterilization by a 0.22 mu m filter screen, and preserving at-20 ℃.
3. The method according to claim 1, wherein the 10% FBS-DMEM: FBS+DMEM+P/S, stored at 4deg.C.
4. The method of claim 1, wherein the primary cells are passaged less than 10 passages to avoid possible genetic and phenotypic changes.
CN202111097340.7A 2021-09-18 2021-09-18 A method for culturing primary glioma-related fibroblasts Active CN113736737B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111097340.7A CN113736737B (en) 2021-09-18 2021-09-18 A method for culturing primary glioma-related fibroblasts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111097340.7A CN113736737B (en) 2021-09-18 2021-09-18 A method for culturing primary glioma-related fibroblasts

Publications (2)

Publication Number Publication Date
CN113736737A CN113736737A (en) 2021-12-03
CN113736737B true CN113736737B (en) 2023-09-08

Family

ID=78739893

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111097340.7A Active CN113736737B (en) 2021-09-18 2021-09-18 A method for culturing primary glioma-related fibroblasts

Country Status (1)

Country Link
CN (1) CN113736737B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114350601B (en) * 2021-12-21 2022-12-27 广东省华晟生物技术有限公司 Cherry valley duck fibroblast line and construction method and application thereof
CN119876035A (en) * 2025-03-28 2025-04-25 南昌大学 Method for constructing tumor organoid and fibroblast high-flux medicine sieve model

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109694852A (en) * 2019-02-22 2019-04-30 武汉赛尔朗灵科技有限公司 A kind of people's glioma primary cell and its In-vitro separation culture method and application
CN111876386A (en) * 2020-08-10 2020-11-03 上海市第一人民医院 A method for culturing breast cancer organoids and co-culturing method with tumor-associated fibroblasts
CN115491344A (en) * 2022-09-16 2022-12-20 南昌大学 A method for the isolation, purification and in vitro activation model construction of mouse primary lung fibroblasts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150297613A1 (en) * 2011-12-13 2015-10-22 Servicio Andaluz De Salud Use of agents that alter the peritumoral environment for the treatment of cancer
AU2018375151B2 (en) * 2017-11-29 2025-06-26 Spinalcyte Llc Interaction of fibroblasts and immune cells for activation and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109694852A (en) * 2019-02-22 2019-04-30 武汉赛尔朗灵科技有限公司 A kind of people's glioma primary cell and its In-vitro separation culture method and application
CN111876386A (en) * 2020-08-10 2020-11-03 上海市第一人民医院 A method for culturing breast cancer organoids and co-culturing method with tumor-associated fibroblasts
CN115491344A (en) * 2022-09-16 2022-12-20 南昌大学 A method for the isolation, purification and in vitro activation model construction of mouse primary lung fibroblasts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells;Pravin J.Mishra;Cancer Research;第68卷(第11期);第4331-4339页 *

Also Published As

Publication number Publication date
CN113736737A (en) 2021-12-03

Similar Documents

Publication Publication Date Title
CN114292816B (en) Lung cancer organoid culture solution, and culture reagent combination and culture method thereof
CN114317443A (en) Breast cancer organoid culture solution, and culture reagent combination and culture method thereof
CN113736737B (en) A method for culturing primary glioma-related fibroblasts
CN121136924A (en) Mesenchymal stem cell membrane and preparation method thereof
CN104480533A (en) Placenta stem cell bank construction method and placenta tissue resuscitation method
CN105543164A (en) Primary isolated culture method for dairy cow mammary epithelial cells
CN114540276A (en) Three-dimensional culture method for in-vitro endometrial gland organs
CN113462639A (en) Method for separating fibroblasts from human induced pluripotent stem cells and application of method
CN108300688A (en) Primary hepatocyte detaches and cultural method
CN115851587A (en) Optimized culture medium, kit and culture method of human placenta-derived mesenchymal stem cells
CN116836934B (en) Osteosarcoma organoid culture solution, culture reagent combination and culture method
CN107354130A (en) A kind of intermembranous mesenchymal stem cells separation method of human placenia
CN115322964B (en) Construction method of 3D culture amniotic mesenchymal stem cell seed bank
CN108865977A (en) A kind of newborn rat skin end septal cell massive amplification method and application
CN105695401B (en) The preparation of all stem cells of a kind of umbilical artery and vein blood vessel and store method
CN116836933B (en) Liver and gall cancer organoid culture solution, culture reagent combination and culture method
CN108660108A (en) A kind of method enhancing umbilical cord mesenchymal stem cells immunoregulation capability
CN111004782B (en) Primary human intestinal cancer cell and culture method and application thereof
CN114276986A (en) A method for separating and purifying buffalo primary myoblasts and its application
CN119709618B (en) A method for sorting mature RPE cells from iPSC-differentiated cells and its application
CN114058573B (en) A culture medium containing biotin
WO2022056991A1 (en) Mesenchymal stem cells derived from umbilical cord, and preparation method therefor and use thereof
CN115232792B (en) Culture medium and culture method for pleural fluid source organoid
CN111979176B (en) Preparation method of human corneal epithelial cells, conditioned medium thereof and preparation method thereof
CN113430229B (en) Construction method of human-derived BAV-TAA disease pluripotent stem cell model

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant